Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol.
about
Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution.Fighting Ebola: A Window for Vaccine Re-evaluation?A comparison of host gene expression signatures associated with infection in vitro by the Makona and Ecran (Mayinga) variants of Ebola virus.Human genetic variation in VAC14 regulates Salmonella invasion and typhoid fever through modulation of cholesterol.Toremifene interacts with and destabilizes the Ebola virus glycoproteinHost Factors Involved in Ebola Virus Replication.Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and Ebola virus interactions.Filovirus Strategies to Escape Antiviral Responses.The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells.Production and Purification of Filovirus Glycoproteins in Insect and Mammalian Cell Lines.Target identification and mode of action of four chemically divergent drugs against Ebola virus infection.Transmembrane Domains of Highly Pathogenic Viral Fusion Proteins Exhibit Trimeric Association In Vitro.Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin AntagonismGenetic variation in is associated with bacteremia secondary to diverse pathogens in African children
P2860
Q28076034-447A13EF-399F-46AC-83C4-9951F1C165D9Q33551748-ED9D32AC-51C4-4DCC-9F82-0231F929E961Q36247762-0C7E3EF3-4334-4DCF-80E4-4C9B8E593A78Q37667895-1075893E-5538-4A98-A976-B91FD942C860Q38694468-BE73A811-2C2A-45CB-8A67-EEB6085DA1F4Q38760720-932EE0D5-9A9E-42BD-AD05-0DA737A2E83CQ39436358-1C9AAF37-8C59-426B-ACE3-E3B2AADE5E3DQ39840325-D18C628D-65CB-4E00-8AB3-8ED850A6C9E7Q40132236-779F7E3D-3395-4F22-9529-FBD25442AD89Q45323651-9E447C5D-0741-4689-A8C1-2EB89F1F1EF5Q45346814-2B92BC5A-33CE-4687-AAD5-23154FD7D6C3Q47260721-91A0745B-5F8E-469C-9243-2CA6951C95FDQ52579717-86941E70-AEA9-4C1B-9CFE-452D4A7BA160Q52714949-824EAABC-D87B-41C1-AF84-276AD83047C0Q57252413-CE29061C-4EDA-4732-9927-1AB75855A078Q57611923-2F4F97FA-F2EF-4017-B251-E6D79FECE0F9
P2860
Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition of Ebola virus glyc ...... mbrane domain and cholesterol.
@en
type
label
Inhibition of Ebola virus glyc ...... mbrane domain and cholesterol.
@en
prefLabel
Inhibition of Ebola virus glyc ...... mbrane domain and cholesterol.
@en
P2093
P2860
P921
P356
P1476
Inhibition of Ebola virus glyc ...... embrane domain and cholesterol
@en
P2093
Andrea Hellwig
Andreas M Ernst
Britta Brügger
Felix Wieland
Moritz Hacke
Patricia Himmels
P2860
P2888
P356
10.1038/NCOMMS8688
P407
P577
2015-07-09T00:00:00Z